Litcius/Paper detail

Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial

Gerrit Burkhardt, Ulrike Kumpf, Alexander Crispin, Stephan Goerigk, Elisabeth André, Christian Plewnia, Bettina Brendel, Andreas J. Fallgatter, Berthold Langguth, Mohamed A. Abdelnaim, Tobias Hebel, Claus Normann, Lukas Frase, Peter Zwanzger, Julia Diemer, Thomas Kammer, Carlos Schönfeldt‐Lecuona, Daniel Kamp, Malek Bajbouj, Nora Behler, Anja Wilkening, Tabea Nenov-Matt, Esther Dechantsreiter, Daniel Keeser, Lucia Bulubas, Ulrich Palm, Christiane Blankenstein, Ulrich Mansmann, Peter Falkai, André R. Brunoni, Alkomiet Hasan, Frank Padberg

2023The Lancet92 citationsDOI

Topics & Concepts

Major depressive disorderTranscranial direct-current stimulationAntidepressantRandomized controlled trialSerotonin reuptake inhibitorPopulationMedicineRating scaleDepression (economics)Major depressive episodeHamilton Rating Scale for DepressionInternal medicinePsychiatryPsychologyStimulationAnxietyMoodEconomicsDevelopmental psychologyMacroeconomicsEnvironmental healthTranscranial Magnetic Stimulation StudiesElectroconvulsive Therapy StudiesNeuroethics, Human Enhancement, Biomedical Innovations
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial | Litcius